196 related articles for article (PubMed ID: 37544015)
1. PSMA-Hornet: Fully-automated, multi-target segmentation of healthy organs in PSMA PET/CT images.
Klyuzhin IS; Chaussé G; Bloise I; Harsini S; Ferres JL; Uribe C; Rahmim A
Med Phys; 2024 Feb; 51(2):1203-1216. PubMed ID: 37544015
[TBL] [Abstract][Full Text] [Related]
2. Automated segmentation of lesions and organs at risk on [
Yazdani E; Karamzadeh-Ziarati N; Cheshmi SS; Sadeghi M; Geramifar P; Vosoughi H; Jahromi MK; Kheradpisheh SR
Cancer Imaging; 2024 Feb; 24(1):30. PubMed ID: 38424612
[TBL] [Abstract][Full Text] [Related]
3. Automatic segmentation of prostate cancer metastases in PSMA PET/CT images using deep neural networks with weighted batch-wise dice loss.
Xu Y; Klyuzhin I; Harsini S; Ortiz A; Zhang S; Bénard F; Dodhia R; Uribe CF; Rahmim A; Lavista Ferres J
Comput Biol Med; 2023 May; 158():106882. PubMed ID: 37037147
[TBL] [Abstract][Full Text] [Related]
4. Analytical performance of aPROMISE: automated anatomic contextualization, detection, and quantification of [
Johnsson K; Brynolfsson J; Sahlstedt H; Nickols NG; Rettig M; Probst S; Morris MJ; Bjartell A; Eiber M; Anand A
Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):1041-1051. PubMed ID: 34463809
[TBL] [Abstract][Full Text] [Related]
5. PSMA-PET improves deep learning-based automated CT kidney segmentation.
Leube J; Horn M; Hartrampf PE; Buck AK; Lassmann M; Tran-Gia J
Z Med Phys; 2024 May; 34(2):231-241. PubMed ID: 37666698
[TBL] [Abstract][Full Text] [Related]
6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
7. Semiquantitative Parameters in PSMA-Targeted PET Imaging with [
Sahakyan K; Li X; Lodge MA; Werner RA; Bundschuh RA; Bundschuh L; Kulkarni HR; Schuchardt C; Baum RP; Pienta KJ; Pomper MG; Ross AE; Gorin MA; Rowe SP
Mol Imaging Biol; 2020 Feb; 22(1):181-189. PubMed ID: 31115751
[TBL] [Abstract][Full Text] [Related]
8. A convolutional neural network-based system for fully automatic segmentation of whole-body [
Jafari E; Zarei A; Dadgar H; Keshavarz A; Manafi-Farid R; Rostami H; Assadi M
Eur J Nucl Med Mol Imaging; 2024 Apr; 51(5):1476-1487. PubMed ID: 38095671
[TBL] [Abstract][Full Text] [Related]
9. [
Green MA; Hutchins GD; Bahler CD; Tann M; Mathias CJ; Territo W; Sims J; Polson H; Alexoff D; Eckelman WC; Kung HF; Fletcher JW
Mol Imaging Biol; 2020 Jun; 22(3):752-763. PubMed ID: 31429050
[TBL] [Abstract][Full Text] [Related]
10. Semiquantitative Parameters in PSMA-Targeted PET Imaging with [
Werner RA; Bundschuh RA; Bundschuh L; Lapa C; Yin Y; Javadi MS; Buck AK; Higuchi T; Pienta KJ; Pomper MG; Lodge MA; Gorin MA; Rowe SP
Mol Imaging Biol; 2020 Feb; 22(1):190-197. PubMed ID: 31140110
[TBL] [Abstract][Full Text] [Related]
11. Deep learning-based whole-body PSMA PET/CT attenuation correction utilizing Pix-2-Pix GAN.
Ma KC; Mena E; Lindenberg L; Lay NS; Eclarinal P; Citrin DE; Pinto PA; Wood BJ; Dahut WL; Gulley JL; Madan RA; Choyke PL; Turkbey IB; Harmon SA
Oncotarget; 2024 May; 15():288-300. PubMed ID: 38712741
[TBL] [Abstract][Full Text] [Related]
12. F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients.
Giesel FL; Hadaschik B; Cardinale J; Radtke J; Vinsensia M; Lehnert W; Kesch C; Tolstov Y; Singer S; Grabe N; Duensing S; Schäfer M; Neels OC; Mier W; Haberkorn U; Kopka K; Kratochwil C
Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):678-688. PubMed ID: 27889802
[TBL] [Abstract][Full Text] [Related]
13. Fully automatic prognostic biomarker extraction from metastatic prostate lesion segmentations in whole-body [
Kendrick J; Francis RJ; Hassan GM; Rowshanfarzad P; Ong JSL; Ebert MA
Eur J Nucl Med Mol Imaging; 2022 Dec; 50(1):67-79. PubMed ID: 35976392
[TBL] [Abstract][Full Text] [Related]
14. Intraindividual Comparison of
Giesel FL; Will L; Lawal I; Lengana T; Kratochwil C; Vorster M; Neels O; Reyneke F; Haberkon U; Kopka K; Sathekge M
J Nucl Med; 2018 Jul; 59(7):1076-1080. PubMed ID: 29269569
[TBL] [Abstract][Full Text] [Related]
15. Small Molecule, Multimodal, [
Aras O; Demirdag C; Kommidi H; Guo H; Pavlova I; Aygun A; Karayel E; Pehlivanoglu H; Yeyin N; Kyprianou N; Chen N; Harmsen S; Sonmezoglu K; Lundon DJ; Oklu R; Ting R; Tewari A; Akin O; Sayman HB
Clin Genitourin Cancer; 2021 Oct; 19(5):405-416. PubMed ID: 33879400
[TBL] [Abstract][Full Text] [Related]
16. Semiquantitative Parameters in PSMA-Targeted PET Imaging with
Li X; Rowe SP; Leal JP; Gorin MA; Allaf ME; Ross AE; Pienta KJ; Lodge MA; Pomper MG
J Nucl Med; 2017 Jun; 58(6):942-946. PubMed ID: 27932557
[No Abstract] [Full Text] [Related]
17. Validation of different PSMA-PET/CT-based contouring techniques for intraprostatic tumor definition using histopathology as standard of reference.
Zamboglou C; Fassbender TF; Steffan L; Schiller F; Fechter T; Carles M; Kiefer S; Rischke HC; Reichel K; Schmidt-Hegemann NS; Ilhan H; Chirindel AF; Nicolas G; Henkenberens C; Derlin T; Bronsert P; Mavroidis P; Chen RC; Meyer PT; Ruf J; Grosu AL
Radiother Oncol; 2019 Dec; 141():208-213. PubMed ID: 31431386
[TBL] [Abstract][Full Text] [Related]
18. Deep learning-based quantification of PET/CT prostate gland uptake: association with overall survival.
Polymeri E; Sadik M; Kaboteh R; Borrelli P; Enqvist O; Ulén J; Ohlsson M; Trägårdh E; Poulsen MH; Simonsen JA; Hoilund-Carlsen PF; Johnsson ÅA; Edenbrandt L
Clin Physiol Funct Imaging; 2020 Mar; 40(2):106-113. PubMed ID: 31794112
[TBL] [Abstract][Full Text] [Related]
19. Intraprostatic Tumor Segmentation on PSMA PET Images in Patients with Primary Prostate Cancer with a Convolutional Neural Network.
Kostyszyn D; Fechter T; Bartl N; Grosu AL; Gratzke C; Sigle A; Mix M; Ruf J; Fassbender TF; Kiefer S; Bettermann AS; Nicolay NH; Spohn S; Kramer MU; Bronsert P; Guo H; Qiu X; Wang F; Henkenberens C; Werner RA; Baltas D; Meyer PT; Derlin T; Chen M; Zamboglou C
J Nucl Med; 2021 Jun; 62(6):823-828. PubMed ID: 33127624
[TBL] [Abstract][Full Text] [Related]
20. The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions.
Afshar-Oromieh A; Hetzheim H; Kratochwil C; Benesova M; Eder M; Neels OC; Eisenhut M; Kübler W; Holland-Letz T; Giesel FL; Mier W; Kopka K; Haberkorn U
J Nucl Med; 2015 Nov; 56(11):1697-705. PubMed ID: 26294298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]